Scientists at BMS dig deep into disease biology to truly understand cancer and battle it from multiple angles.
May 05, 2023
Using a multimodal toolbox to advance the next generation of cancer treatment >
Cancer Cells
May 02, 2023
Putting patients first: Transforming clinical lessons into development strategies >
My front row seat to the revolution in immune checkpoint inhibition
April 30, 2023
My front row seat to the revolution in immune checkpoint inhibition >
Dana Walker, MD, MSCE, vice president and Genitourinary Cancers Development Lead, Bristol Myers Squibb
February 06, 2023
Reflecting on research in genitourinary cancers >
January 24, 2023
The power of dual immunotherapy >
December 12, 2022
Biking the globe for C2C4C >
New Approaches to Multiple Myeloma
December 09, 2022
Our bold vision for multiple myeloma >
BCMA
November 17, 2022
Exploring multiple paths to advance BCMA-targeted therapies >
A beacon of hope
October 25, 2022
A beacon of hope >
Group of Cyclists Riding Through Rain
July 28, 2022
C2C4C: Back on the road and bigger than ever >
Today’s cell therapy insights shaping tomorrow
July 20, 2022
Today’s cell therapy insights shaping tomorrow >
abder schoenfeld
May 17, 2022
The evolution of lung cancer research >